Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Zhongguo Zhong Yao Za Zhi ; 44(14): 2953-2959, 2019 Jul.
Artigo em Zh | MEDLINE | ID: mdl-31602839

RESUMO

This study aimed to investigate the protective effect and preliminary mechanism of Danzhi Jiangtang Capsules( DJC) on liver of hyperlipidemic rats. The hyperlipidemia models were successfully made by high-fat diet for 12 weeks in male SD rats,and then divided into model control group and DJC treatment groups( 500 and 1 000 mg·kg~(-1)·d-1) via gavage administration for additional 8 weeks.The levels of serum lipid and liver metabolism indices were detected; HE and oil red O staining were used to observe the pathological changes of liver. Expression levels of extracellular regulated protein kinase 1/2( ERK1/2),c-Jun N-terminal kinase( JNK),and p38 mitogen-activated protein kinase( p38 MAPK) were detected by real-time polymerase chain reaction( RT-PCR). Expression of MCP-1,phosphorylated ERK( p-ERK),phosphorylated JNK( p-JNK),and phosphorylated p38 MAPK( p-p38) were analyzed by immunohistochemistry and Western blot. The results showed that DJC decreased body weight and serum levels of total cholesterol( TC),triglyceride( TG),alanine aminotransferase( ALT),aspartate aminotransferase( AST),increased serum high-density lipoprotein cholesterol( HDL-C) level,ameliorate injury and lipid deposition in the liver induced by the high-fat diet,decreased mRNA expression of ERK1/2,JNK and p-38 MAPK as well as protein expression of p-ERK,p-JNK,p-p38,and MCP-1,somewhat showing a dose-dependent effect. Therefore,DJC has an obvious protective effect on liver of hyperlipidemic rats with certain dose-dependent effect,and the mechanism may be related with inhibiting MAPK pathways and inflammation.


Assuntos
Medicamentos de Ervas Chinesas/farmacologia , Hiperlipidemias/tratamento farmacológico , Sistema de Sinalização das MAP Quinases , Animais , Cápsulas , Dieta Hiperlipídica , Inflamação , Fígado/efeitos dos fármacos , Fígado/metabolismo , Masculino , Ratos , Ratos Sprague-Dawley , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismo
2.
J Craniofac Surg ; 23(6): 1699-702, 2012 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-23147328

RESUMO

In the present study, we explored the effects of various endoscopic approaches in patients with cavernous sinus (CS) tumors. Five endoscopic approaches, including the endoscopic transseptal transsphenoidal approach, extended endoscopic transseptal transsphenoidal approach, extended transnasal transmaxillary approach, extranasal extended maxillary sinus approach, and endoscopic transnasal transpterygoid approach, were selected for the resection of CS tumors from 36 patients. Thirty gross total tumors and 6 subtotal tumors were removed. After a follow-up period of 6 months to 3 years, 30 patients were determined to be recurrence-free, and 2 patients had unchanged residual tumors. One patient with a recurrent pituitary adenoma underwent a second surgery, and 1 patient with chordoma died because of an intracavernous carotid artery rupture 18 months after the operation. Various endoscopic approaches tailored to the origin and extent of the CS tumor were proven efficacious for the maximal and precise removal of CS tumors while avoiding vital structures.


Assuntos
Seio Cavernoso/cirurgia , Endoscopia/métodos , Neoplasias de Cabeça e Pescoço/cirurgia , Adolescente , Adulto , Seio Cavernoso/patologia , Criança , Feminino , Neoplasias de Cabeça e Pescoço/patologia , Humanos , Masculino , Pessoa de Meia-Idade , Taxa de Sobrevida , Resultado do Tratamento
3.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 30(6): 617-21, 2010 Jun.
Artigo em Zh | MEDLINE | ID: mdl-20815278

RESUMO

OBJECTIVE: To explore the possible mechanism of total flavonoids of Litsea coreana (TFLC) on reducing blood glucose level in rat with type 2 diabetes mellitus (T2DM). METHODS: Male SD rats of T2DM allocated in two groups were treated with 400 mg/kg TFLC or metformin respectively via gastrogavage for 6 weeks. Blood routine biochemical indices in rats were measured; pathology of rats' liver was examined with HE stain under transmission electron microscopy; levels of malondialdehyde (MDA) and superoxide dismutase (SOD) in liver homogenate were determined, and the expression of protein tyrosine phosphatase 1B (PTP1B) in liver was detected using RT-PCR at the terminal of the experiment. RESULTS: Biochemical measuring showed that the glucose tolerance of rats after treatment was markedly improved in both groups. Meantime, levels of fast blood glucose (FBG), glycohemoglobin (HbA1c), fast blood insulin (FINS), free fatty acid (FFA), total cholesterol (TC), triglyceride (TG) and low density lipoprotein-cholesterol (LDL-C), as well as MDA level in liver were decreased, while levels of high density lipoprotein-cholesterol (HDL-C) in blood and SOD in liver were significantly increased in both groups after treatment, showing insignificant difference between two treatment groups. Light microscopic examination showed markedly fatty degeneration of liver, and electron microscopic examination found mitochondria swelling and endoplasmic reticulum breakage in liver of T2DM rats, but these changes were ameliorated to some extent after treatment. The elevated PTP1B expression in liver of T2DM rats was decreased in the TFLC treated group, but unchanged in the metformin treated group. CONCLUSION: TFLC can significantly decrease the blood levels of glucose and lipid and ameliorate oxidation stress in liver; its mechanism of action in improving insulin resistance might be related with its suppression on PTP1B expression in rat's liver to enhance the insulin signaling pathway.


Assuntos
Glicemia/metabolismo , Diabetes Mellitus Experimental/tratamento farmacológico , Diabetes Mellitus Tipo 2/tratamento farmacológico , Flavonoides/uso terapêutico , Litsea/química , Animais , Flavonoides/isolamento & purificação , Hipoglicemiantes/uso terapêutico , Fígado/metabolismo , Masculino , Estresse Oxidativo/efeitos dos fármacos , Proteína Tirosina Fosfatase não Receptora Tipo 1/metabolismo , Ratos , Ratos Sprague-Dawley
4.
Zhonghua Yan Ke Za Zhi ; 45(9): 776-80, 2009 Sep.
Artigo em Zh | MEDLINE | ID: mdl-20137280

RESUMO

OBJECTIVE: To determine and compare the prevalence and causes of visual disability in urban and rural areas of Hubei province. METHODS: A cross-sectional study. From April 1 to May 31 in 2006, based on a stratified, multi-stage, cluster-sampling strategy, 31 counties (cities, districts), 124 townships (towns, streets), altogether 248 investigation districts, 101 674 sample individuals from Hubei province were selected to conduct inquiry registration, screening and visual disability evaluation. The revised 'Criteria of Disability' formulated by the specialist committee of the 2nd National Sample Survey of Disability was applied. The diagnosis and grading of visual disability were based on history of illness and vision function examination. The etiology diagnosis was made according to the causes of disability and the causing diseases. Chi-square test was used to investigate differences due to gender, age, and areas (urban and rural). RESULTS: The overall prevalence rate of visual disability in Hubei province is 1.40% (95%CI: 1.33% - 1.47%). The rate is 0.93% (95%CI: 0.88% - 0.98%) for urban areas and 1.62% (95%CI: 1.24% - 2.00%) for rural areas. Rural areas have a higher rate than urban ones and the difference is statistically significant (chi(2) = 68.2410, P < 0.0001). The rate increases with age in both urban and rural areas. In age groups older than 10, the prevalence rate in rural areas is higher than urban areas, and the difference becomes significant (chi(2) = 33.6569, P < 0.0001) for age groups 30-80. Females have a higher rate (1.63%) than males (1.18%) (chi(2) = 37.8386, P < 0.0001). The main eye diseases causing visual disability in urban areas are cataract (53.77%), retinopathy and choroidopathy (10.82%), ametropia (7.87%), glaucoma (6.23%) and hereditary/congenital diseases and developmental disorders (5.90%). The main causing diseases in rural areas are cataract (48.61%), corneal diseases (14.17%), glaucoma (6.91%), retinopathy and choroidopathy (6.19%) and hereditary/congenital diseases and developmental disorders (5.20%). CONCLUSIONS: The rural areas have a higher prevalence rate of visual disability than urban areas in Hubei province. Cataract is the leading cause of visual disability. We should continue the work of prevention and cure of visual disability, the primary work being cataract surgery. More stress should be placed on the prevention and cure effort in rural areas and for females and elderly people.


Assuntos
Transtornos da Visão/epidemiologia , Adolescente , Adulto , Distribuição por Idade , Idoso , Idoso de 80 Anos ou mais , Cegueira/epidemiologia , Catarata/complicações , Criança , Pré-Escolar , China/epidemiologia , Estudos Transversais , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Pessoa de Meia-Idade , Prevalência , População Rural , Distribuição por Sexo , População Urbana , Adulto Jovem
5.
Life Sci ; 157: 158-167, 2016 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-27297630

RESUMO

AIMS: Fenofibrate (FF) is commonly used clinically as a lipid-lowering drug, but whether it participates in endoplasmic reticulum (ER) stress and decreases inflammation in skeletal muscle is still unknown. The aim of this study is to determine whether FF treatment reduces insulin resistance (IR) by alleviating ER stress and downstream inflammation in skeletal muscle tissues and cells. MAIN METHODS: Female SD rats were randomly divided into groups receiving the standard chow diet (SCD), a high-fat diet (HFD), or HFD plus FF (HFD+FF). The rats in the latter two groups were subjected to a standard HFD for 20weeks, then the HFD+FF rats were administered FF (30mg/kg once daily via gavage) for another 8weeks. Whole-body IR, expression of peroxisome proliferator-activated receptor α (PPARα), ER stress-related genes, and inflammatory genes in the soleus muscle were assessed. The differentiated C2C12 myotubes were treated with palmitic acid or pretreated with fenofibric acid or 4-phenylbutyric acid (4-PBA), etomoxir, and the expression of ER stress, beta-oxidation-related genes, inflammatory genes, Toll-like receptor 4 (TLR4), and insulin-signaling-related molecules were determined. KEY FINDINGS: Eight weeks of FF treatment attenuated HFD-induced IR by decreased tribbles 3 (TRB3) expression, ER stress and inflammation in skeletal muscle. FA pretreatment markedly inverted the PA-induced expression of TLR4 and downstream inflammatory genes, activated ER stress, improved ß-oxidation and insulin signaling in differentiated myotube cells. SIGNIFICANCE: FF treatment significantly improved HFD-induced IR in skeletal muscle and PA-induced IR in myotube cells, which may be related to reduced ER stress-induced inflammation.


Assuntos
Dieta Hiperlipídica , Estresse do Retículo Endoplasmático/efeitos dos fármacos , Fenofibrato/farmacologia , Inflamação/induzido quimicamente , Músculo Esquelético/efeitos dos fármacos , Ácido Palmítico/farmacologia , Animais , Peso Corporal/efeitos dos fármacos , Linhagem Celular , Feminino , Camundongos , Músculo Esquelético/patologia , Ratos , Ratos Sprague-Dawley
6.
Enzyme Microb Technol ; 73-74: 72-9, 2015 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-26002507

RESUMO

To identify the fuctions of the nine putative O-methyltransferase genes in Streptomyces virginiae IBL14, the evolutionary and functional relationship of these genes in its 8.0 Mb linear chromosome was set up via sequence comparison with those of other Streptomyces species. Further, the functions and catalytic mechanism of the three genes sviOMT02, sviOMT03 and sviOMT06 from this strain were studied through experimental and computational approaches. As a result, the nine putative O-methyltransferases belong to methyltransf_2 superfamily, amdomet-MTases superfamily, and leucine carboxyl methyltransferase superfamily, and are phylogenetically close to those of Streptomyces sp. C. The products of genes sviOMT03 and sviOMT06 could catalyze O-methylation of caffeic acid to form ferulic acid. Computational analysis indicated that the O-methylation mechanism of SviOMT03 and SviOMT06 proceeds from a direct transfer of the SAM-methyl group to caffeic acid with inversion of symmetry aided by a divalent metal ion in a SN2-like mechanism. Particularly, the conservative polar amino acid residues in SviOMT03 and SviOMT06, including Lys143 that reacts with caffeic acid, Ser74, Asp140 and Tyr149 that react with S-adenosyl methionine, and His142 (SviOMT03) or His171 (SviOMT06) that transfers the 3-hydroxyl proton of substrate caffeic acid, probably be essential in their O-methylation.


Assuntos
Proteínas de Bactérias/metabolismo , Streptomyces/enzimologia , Sequência de Aminoácidos , Proteínas de Bactérias/genética , Catálise , Cátions Bivalentes/metabolismo , Clonagem Molecular , Metilação , Mutagênese Sítio-Dirigida , Fosforilação , Filogenia , Processamento de Proteína Pós-Traducional , Alinhamento de Sequência , Homologia de Sequência de Aminoácidos , Streptomyces/genética , Especificidade por Substrato
7.
Biomed Environ Sci ; 17(2): 196-202, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15386945

RESUMO

OBJECTIVE: To study the relationship between drinking environment, attitudes and situation and alcohol-related health problems. METHODS: A sample of 2327 respondents was randomly collected from Wuhan, Hubei Province in China by a face-to-face interview. The structural equation modeling analysis was performed for the data collected. RESULTS: Both parents' drinking behaviors and respondents' drinking situation strongly impacted the alcohol-related problems and diseases. Friends' or peers' drinking behaviors influenced the respondents' drinking attitudes and behaviors. Males experienced more alcohol-related problems and diseases than females. CONCLUSIONS: Comparatively, parents' drinking behaviors exert the most significant influence on drinkers. Therefore, it is beneficial to restrict parents' drinking behaviors for the offsprings and the whole society, and an intensive professional education in early motherhood is also necessary for Chinese women.


Assuntos
Consumo de Bebidas Alcoólicas/epidemiologia , Transtornos Relacionados ao Uso de Álcool/epidemiologia , Adolescente , Adulto , Fatores Etários , Idoso , Consumo de Bebidas Alcoólicas/tendências , Atitude , Comportamento , China/epidemiologia , Cidades , Análise Fatorial , Saúde da Família , Feminino , Amigos , Humanos , Masculino , Pessoa de Meia-Idade , Modelos Estatísticos , Fatores Sexuais , Inquéritos e Questionários
8.
World J Gastrointest Endosc ; 4(11): 506-12, 2012 Nov 16.
Artigo em Inglês | MEDLINE | ID: mdl-23189222

RESUMO

AIM: To study if the angiotensin II receptor blockers (ARB) losartan counteracts pancreatic hyperenzymemia as measured 24 h after endoscopic retrograde cholangiopancreatography (ERCP). METHODS: A triple-blind and placebo-controlled randomized clinical trial was performed at two Swedish hospitals in 2006-2008. Patients over 18 years of age undergoing ERCP, excluding those with current pancreatitis, current use of ARB, and severe disease, such as sepsis, liver and renal failure. One oral dose of 50 mg losartan or placebo was given one hour before ERCP. The relative risk of hyperenzymemia 24 h after ERCP was estimated using multivariable logistic regression, and expressed as odds ratio with 95% confidence intervals (CIs), including adjustment for potential remaining confounding. RESULTS: Among 76 participating patients, 38 were randomized to the losartan and the placebo group, respectively. The incidence rates of hyperenzymemia and acute pancreatitis among all 76 participating patients were 21% and 12%, respectively. Hyperenzymemia was detected in 9 and 7 patients in the losartan and placebo group, respectively. There were no major differences between the comparison groups regarding cannulation difficulty, findings, or proportion of patients requiring drainage of the bile ducts. There were, however, more pancreatic duct injections, a greater extent of pancreatography, and more biliary sphincterotomies in the losartan group than in the placebo group. Losartan was not associated with risk of hyperenzymemia compared to the placebo group after multi-varible logistic regression analysis (odds ratio 1.6, 95%CI 0.3-7.8). CONCLUSION: In this randomized trial 50 mg losartan given orally had no prophylactic effect on development of hyperenzymemia after ERCP.

9.
Artigo em Zh | MEDLINE | ID: mdl-21429341

RESUMO

OBJECTIVE: To explore the techniques, advantages and disadvantages, indications and cautions of a surgical approach for the resection of nasopharyngeal tumor. METHODS: Ten cases with nasopharyngeal tumors were recruited in this study, of them, 3 cases with residual nasopharyngeal carcinoma after chemoradiotherapy, 2 cases with cavernous angioma, 2 cases with benign mixed tumor, 1 malignant mixed tumor, 1 adenoid cystic carcinoma, and 1 chordoma. All patients underwent endoscopic resection of posteroinferior quarter part of nasal septum, and then the removal of nasopharyngeal tumors through bilateral transnasal approach. RESULTS: Total resection of the tumor was achieved for all cases without severe surgical complications. All cases with benign tumors, with following-up of 6-18 months, showed no recurrence. Of 6 cases with malignant tumors, with following-up of 12-48 months, 5 cases showed no recurrence, and 1 case was suspected to relapse one year postoperatively, but not with any lesion enlargement after another 6 month follow-up. CONCLUSIONS: Posteroinferior quarter part of nasal septectomy is preferred for endoscopic resection of nasopharyngeal tumors because it can provide a panoramic view on nasopharyngeal cavity and tumors, thus, facilitating the removal of nasopharyngeal tumors.


Assuntos
Endoscopia/métodos , Septo Nasal/cirurgia , Neoplasias Nasofaríngeas/cirurgia , Adulto , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Resultado do Tratamento , Adulto Jovem
10.
Am J Chin Med ; 38(4): 713-25, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20626057

RESUMO

This study was initiated to determine the possible antidiabetic effects of total flavonoids of Litsea Coreana leve (TFLC), an alcohol extract from the dried leaves of Litsea Coreana leve, on type 2 diabetic rats. Male Sprague-Dawley rats (n = 40, 160-180 g) were divided into two groups and fed with normal chow diet (Normal Control group) or high-fat diet (HFD) for a period of 4 weeks. After 4 weeks of dietary manipulation, the HFD-fed rats were injected with 30 mg/kg streptozocin (STZ) to induce diabetes 72 hours after STZ injection. These diabetic rats were randomly divided into 3 groups (n = 10): Diabetic Control group, Diabetic + TFLC group and Diabetic + PIO group. Diabetic + TFLC group and Diabetic + PIO group were orally administered with 400 mg/kg TFLC or 10 mg/kg pioglitazone (all suspended in 0.5% CMC-Na) respectively for 6 weeks. All rats were examined for body weight, serum and hepatic biochemical indices, content of malondialdehyde (MDA), activities of superoxide dismutase (SOD) and pathological changes in liver and pancreas, as well as protein tyrosine phosphatase 1B (PTP1B) expression in liver. The diabetic rats became obese, insulin resistant, hyperglycemic and hyperlipidemic. Treatment with TFLC showed a significant increase in insulin sensitivity, serum HDL-C level and SOD activities, meanwhile marked decrease in body weight, serum FFA, TC, TG, LDL-C, CRP, MDA content. TFLC also attenuated pathologic alterations in liver and pancreatic islet. Furthermore, TFLC was found to decrease the expression of PTP1B in diabetic rat liver. These results suggested that TFLC could ameliorate hyperglycemia, hyperlipoidemia, inflammation and oxidation stress, as well as insulin resistance of type 2 diabetic rats.


Assuntos
Antioxidantes/uso terapêutico , Diabetes Mellitus Experimental/tratamento farmacológico , Gorduras na Dieta/administração & dosagem , Flavonoides/uso terapêutico , Hipoglicemiantes/uso terapêutico , Litsea/química , Extratos Vegetais/uso terapêutico , Animais , Antioxidantes/farmacologia , Peso Corporal/efeitos dos fármacos , Proteína C-Reativa/metabolismo , Diabetes Mellitus Experimental/sangue , Diabetes Mellitus Experimental/patologia , Flavonoides/farmacologia , Hipoglicemiantes/farmacologia , Resistência à Insulina , Ilhotas Pancreáticas/efeitos dos fármacos , Ilhotas Pancreáticas/patologia , Lipídeos/sangue , Fígado/efeitos dos fármacos , Fígado/patologia , Masculino , Malondialdeído/sangue , Fitoterapia , Pioglitazona , Extratos Vegetais/farmacologia , Folhas de Planta , Proteína Tirosina Fosfatase não Receptora Tipo 1/metabolismo , Ratos , Ratos Sprague-Dawley , Superóxido Dismutase/sangue , Tiazolidinedionas/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA